The alarming expansion of this dysfunction imposes scientific innovation suitable for this world- wide challenge. In 2022 the estimated total had risen to 750 million, of which 4-to-6 in Italy, with a constant rate of growth.
After about 50 years of therapies focused on acoustics (masking) or psycho-perceptive and behavioural dysfunction (eg.: TRT or CBT), the increase in sufferers has generated a sudden “proliferation of remedies of all kinds”.
For now, there are no solutions with clinical results comparable to what Acufree achieved in 2023 after 7 years of careful and repeatedly tested specialist patient care.